Le Lézard
Classified in: Health
Subject: SVY

Global Infusion Devices Market Forecast 2018-2028 - Visiongain Report


LONDON, August 20, 2018 /PRNewswire/ --

Syringe, Insulin, Volumetric, Ambulatory, Patient Controlled Analgesia, Implantable, Enteral, Gastroenterology, Diabetes, Analgesia & Pain Management, Chemotherapy, Paediatrics & Neonatology, Hospital, Home Healthcare, Ambulatory Surgical Centres 

The global infusion devices market was valued at $2.1bn in 2017 and is estimated to reach $3.9bn by 2028, growing at a CAGR of 5.6% from 2018-2028. In 2017, the volumetric infusion pumps submarket was the largest contributor to the global infusion devices market by product type.

     (Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 176-page report you will receive 88 tables and 46 figures- all unavailable elsewhere.

The 176-page report provides clear detailed insight into the global infusion devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope
Global Infusion Devices market forecasts from 2018-2028

? This report also breaks down the revenue forecast for global infusion devices market by product type:
? Syringe Infusion Pumps
? Insulin Infusion Pumps
? Volumetric Infusion Pumps
? Ambulatory Infusion Pumps
? Patient Controlled Analgesia Pumps
? Implantable Infusion Pumps
? Enteral Infusion Pumps

? This report also breaks down the revenue forecast for global infusion devices market by application:
? Gastroenterology
? Diabetes
? Analgesia & Pain Management
? Chemotherapy
? Paediatrics & Neonatology
? Other Applications

? This report also breaks down the revenue forecast for global infusion devices market by end-user:
? Hospital
? Home Healthcare
? Ambulatory Surgical Centres
? Other End-User

? This report also breaks down the revenue forecast for global infusion devices market by regional and national market:
? North America: US, Mexico, Canada
? Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Rest of Europe
? Asia-Pacific: Japan, China, Australia, India, South Korea, Rest of Asia-Pacific
? LAMEA: Brazil, Turkey, Saudi Arabia, Republic of South Africa, Rest of LAMEA

Each regional market is further segmented by product type, application, end-user and country 

? This report discusses 10 leading companies involved in the infusion devices market. It contains overviews of the companies' activities, strategies and recent financial results:
? Baxter International Inc.
? B. Braun Melsungen AG
? Becton, Dickinson and Company
? CME Medical UK Ltd.
? Fresenius SE & Co. KGaA
? ICU Medical, Inc.
? Johnson & Johnson
? Moog Inc.
? Smiths Group plc
? Terumo Medical Corporation

? This report provides Porter's Five Forces Analysis of the global infusion devices market. This report also discusses factors that drive and restrain the market as well as opportunities in the market. Moreover, this report provides an analysis on patent and top winning strategies.

Visiongain's study is for everybody needing commercial analyses for the Infusion Devices market and leading companies. You will find data, trends and predictions. Please order our report now.

Buy our report today Global Infusion Devices Market Forecast 2018-2028: Syringe, Insulin, Volumetric, Ambulatory, Patient Controlled Analgesia, Implantable, Enteral, Gastroenterology, Diabetes, Analgesia & Pain Management, Chemotherapy, Paediatrics & Neonatology, Hospital, Home Healthcare, Ambulatory Surgical Centres

To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website : https://www.visiongain.com/report/global-infusion-devices-market-forecast-2018-2028/

Abbott Nutrition 
Akas Medical
Alcor Scientific
Alkermes
Allied Medical
Altea Therapeutics
Amerinet
Amsino International
Animas Corporation
Aradigm
Arcomed AG
Asante
B. Braun Melsungen AG
Baxter 
Bayer Healthcare
Becton & Dickson & Co
Bio-Med
BMS
Boston Scientific Corporation
Caesarea Medical Electronics (CME)
Calibra Medical
Cardinal Health
CareFusion
Celgene
Cellnovo
Celsus Laboratories
CeQur
CME Medical
Codman and Shurtleff
Conmed Corporation
Cook Medical
Covidien
D. Medical Industries
Danone Nutricia
Debiotech
DePuy
Disetronic Medical Systems
DreaMed Diabetes
Eli Lilly
Emco
Emisphere
Fresenius Kabi
GE Medical
Generex Biotechnology Corporation
Glycologic
Hanraj Nayyar Medical India
Hospira 
IBM?
ICU Medical
I-Flow
Insulet Corporation
Intercell
Johnson and Johnson
Kimberly Clark Corporation
Medingo
Medsolve Technologies
Medtronic
Micrel Medical Devices
Mindray
Moog
NeoDevices
NeoMed
Nestle Healthcare
NiliMEDIX
Novartis
Noven Pharmaceuticals
NovoNordisk
Pacira Pharmaceuticals
Philips Medical
pSivida Corporation
Q Core Medical
Roche
Sanofi
Schiller
Smiths Group plc
Smiths Medical
SOOIL
Symbios Medical Products
Takeda
Tandem Diabetics Care
Tandem Diagnostics
Terumo Medical Corporation
Trivitron
Valeritas
Vectura
Vishal Surgical
WalkMed Inc
Zevex

To see a report overview please e-mail Sara Peerun on [email protected]

SOURCE Visiongain


These press releases may also interest you

at 12:32
The countdown has begun for Northern Colorado's most exhilarating fitness competition of the year as "Health4Heroes" gears up to host its highly anticipated 3rd Annual Military and First Responder-inspired "Guardian Games & Expo" on Saturday, May 18,...

at 12:06
A Philadelphia jury has returned a $725.5 million verdict against ExxonMobil, finding the company's failure to warn about known health risks of exposure to cancer-causing benzene in its petroleum products was responsible for a former service station...

at 12:05
Be Biopharma, Inc. ("Be Bio"), a company pioneering the discovery and development of Engineered B Cell Medicines (BCMs), today presented results from new preclinical research demonstrating production of active ALP by a BCM, which highlights BCMs as a...

at 11:50
EGLE Therapeutics, a clinical-stage biotechnology company uniquely positioned to advance the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Pejvack Motlagh MD, MSc, as Chief...

at 11:30
WomenHeart: The National Coalition for Women with Heart Disease, in collaboration with Bayer, is proud to announce the launch of the Understanding Her Heart: Women and Cardiovascular Disease initiative. This groundbreaking partnership aims to bolster...

at 11:15
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the publication of results from SLIM LIVER (also known as A5371) in the Annals of Internal Medicine. "The Effect of Open-Label Semaglutide on...



News published on and distributed by: